This company listing is no longer active
이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Acerus Pharmaceuticals 대차 대조표 상태
재무 상태 기준 확인 0/6
주요 정보
-329.8%
부채 비율
US$45.82m
부채
| 이자 보상 비율 | n/a |
| 현금 | US$3.02m |
| 주식 | -US$13.89m |
| 총 부채 | US$61.57m |
| 총 자산 | US$47.67m |
최근 재무 상태 업데이트
Recent updates
Auditors Have Doubts About Acerus Pharmaceuticals (TSE:ASP)
Mar 14
Have Insiders Been Buying Acerus Pharmaceuticals Corporation (TSE:ASP) Shares?
Mar 12Acerus Pharmaceuticals' (TSE:ASP) Shareholders Are Down 88% On Their Shares
Jan 22The Independent Director of Acerus Pharmaceuticals Corporation (TSE:ASP), Stephen Gregory, Just Bought 52% More Shares
Nov 30
재무 상태 분석
단기부채: ASP has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
장기 부채: ASP has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
부채 대 자본 내역 및 분석
부채 수준: ASP has negative shareholder equity, which is a more serious situation than a high debt level.
부채 감소: ASP's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
대차 대조표
현금 런웨이 분석
과거에 평균적으로 적자를 기록했던 기업의 경우, 최소 1년 이상의 현금 유동성을 보유하고 있는지 평가합니다.
안정적인 현금 활주로: ASP has less than a year of cash runway based on its current free cash flow.
예측 현금 활주로: ASP has less than a year of cash runway if free cash flow continues to reduce at historical rates of 45.6% each year